Ratings by Goldman Sachs (Paul Choi)

Date CompanySymbol Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
5/25/2021 NGM Biopharmaceuticals NGM Maintain Buy
(N/A)
 
 
  Details
5/19/2021 Allakos Inc. ALLK Maintain Neutral
(Neutral)
 
 
  Details
5/14/2021 Odonate Therapeutics ODT Maintain Sell
(N/A)
 
 
  Details
5/13/2021 Frequency Therapeutics FREQ Maintain Buy
(N/A)
 
 
  Details
5/12/2021 Applied Therapeutics APLT Maintain Buy
(N/A)
 
 
  Details
5/12/2021 Phathom Pharmaceuticals PHAT Upgrade Neutral
(Sell)
32.97
(34.71)
5.28% Details
5/12/2021 Amarin Corporation AMRN Downgrade Sell
(Neutral)
4.59
(4.95)
7.84% Details
5/11/2021 FibroGen FGEN Maintain Neutral
(N/A)
 
 
  Details
5/10/2021 BridgeBio Pharma BBIO Maintain Buy
(N/A)
 
 
  Details
3/22/2021 Odonate Therapeutics ODT Maintain Sell
(N/A)
 
 
  Details
3/22/2021 BridgeBio Pharma BBIO Maintain Neutral
(N/A)
 
 
  Details
3/19/2021 Foghorn Therapeutics FHTX Maintain Buy
(N/A)
 
 
  Details
3/11/2021 Vir Biotechnology VIR Maintain Buy
(Buy)
 
 
  Details
3/5/2021 Hutchison China MediTech Ltd. HCM Maintain Buy
(N/A)
 
 
  Details
3/4/2021 Vir Biotechnology VIR Maintain Buy
(Buy)
 
 
  Details
3/4/2021 Magenta Therapeutics MGTA Maintain Buy
(Buy)
 
 
  Details
3/4/2021 PMV Pharmaceuticals Inc. PMVP Maintain Neutral
(Neutral)
 
 
  Details
3/1/2021 Allakos Inc. ALLK Maintain Neutral
(N/A)
 
 
  Details
3/1/2021 Vir Biotechnology VIR Maintain Buy
(N/A)
 
 
  Details
2/26/2021 Vir Biotechnology VIR Maintain Buy
(N/A)
 
 
  Details
2/26/2021 Amarin Corporation AMRN Maintain Neutral
(N/A)
 
 
  Details
2/25/2021 Spring Works Therapeutics SWTX Maintain Buy
(N/A)
 
 
  Details
2/25/2021 Global Blood Therapeutics GBT Maintain Buy
(N/A)
 
 
  Details
2/23/2021 Odonate Therapeutics ODT Maintain Sell
(N/A)
 
 
  Details
2/9/2021 NGM Biopharmaceuticals NGM Maintain Buy
(N/A)
 
 
  Details
2/9/2021 Esperion Therapeutics ESPR Downgrade Sell
(Neutral)
34.08
(26.37)
-22.62% Details
2/9/2021 BridgeBio Pharma BBIO New Coverage Buy
(N/A)
68.28
(63.93)
-6.37% Details
2/1/2021 Turning Point Therapeutics Inc. TPTX Maintain Buy
(N/A)
 
 
  Details
1/29/2021 Turning Point Therapeutics Inc. TPTX Maintain Buy
(N/A)
 
 
  Details
1/13/2021 Turning Point Therapeutics Inc. TPTX Maintain Buy
(Buy)
 
 
  Details
1/7/2021 Radius Health RDUS Maintain Buy
(N/A)
 
 
  Details
1/6/2021 Myovant Sciences Ltd. MYOV Downgrade Neutral
(Buy)
24.07
(22.60)
-6.11% Details
12/30/2020 Hutchison China MediTech Ltd. HCM Maintain Buy
(N/A)
 
 
  Details
12/29/2020 Silverback Therapeutics SBTX New Coverage Buy
(N/A)
35.77
(33.23)
-7.1% Details
12/28/2020 Kinnate Biopharma KNTE New Coverage Buy
(N/A)
37.20
(24.46)
-34.25% Details
12/11/2020 Phathom Pharmaceuticals PHAT Maintain Sell
(N/A)
 
 
  Details
11/10/2020 Spring Works Therapeutics SWTX Maintain Buy
(N/A)
 
 
  Details
11/9/2020 Allakos Inc. ALLK Maintain Neutral
(N/A)
 
 
  Details
11/9/2020 Array Technologies ARRY New Coverage Buy
(N/A)
39.34
(16.15)
-58.95% Details
10/20/2020 PMV Pharmaceuticals Inc. PMVP New Coverage Neutral
(N/A)
35.99
(34.40)
-4.42% Details
9/14/2020 Vir Biotechnology VIR Upgrade Buy
(Neutral)
28.28
(45.53)
61% Details
9/3/2020 Amarin Corporation AMRN Maintain Neutral
(N/A)
 
 
  Details
8/27/2020 UroGen Pharma URGN Maintain Neutral
(N/A)
 
 
  Details
8/17/2020 Applied Therapeutics APLT Maintain Buy
(N/A)
 
 
  Details
8/12/2020 Frequency Therapeutics FREQ Maintain Buy
(N/A)
 
 
  Details
8/11/2020 Pandion Therapeutics PAND New Coverage Buy
(N/A)
19.11
(60.05)
214.23% Details
8/10/2020 UroGen Pharma URGN Maintain Neutral
(N/A)
 
 
  Details
8/6/2020 Axcella Health Inc. AXLA Maintain Buy
(N/A)
 
 
  Details
8/5/2020 Axcella Health Inc. AXLA Maintain Buy
(N/A)
 
 
  Details
7/30/2020 Kiniksa KNSA Maintain Buy
(N/A)
 
 
  Details
7/30/2020 Odonate Therapeutics ODT Maintain Sell
(N/A)
 
 
  Details
7/15/2020 Viela Bio VIE Upgrade Neutral
(Sell)
38.35
(53.01)
38.23% Details
7/1/2020 Global Blood Therapeutics GBT Upgrade Buy
(Neutral)
66.50
(40.64)
-38.89% Details
6/29/2020 Kiniksa KNSA Maintain Buy
(N/A)
 
 
  Details
6/29/2020 Neurocrine Bio. NBIX Downgrade Neutral
(Buy)
130.36
(98.61)
-24.36% Details
6/26/2020 Myovant Sciences Ltd. MYOV Maintain Buy
(N/A)
 
 
  Details
6/26/2020 Phathom Pharmaceuticals PHAT Downgrade Sell
(Neutral)
41.55
(34.71)
-16.46% Details
6/9/2020 NGM Biopharmaceuticals NGM Maintain Buy
(N/A)
 
 
  Details
6/9/2020 Neurocrine Bio. NBIX Maintain Buy
(N/A)
 
 
  Details
6/8/2020 Turning Point Therapeutics Inc. TPTX Maintain Buy
(N/A)
 
 
  Details
6/8/2020 NGM Biopharmaceuticals NGM Maintain Buy
(N/A)
 
 
  Details
6/8/2020 Neurocrine Bio. NBIX Maintain Buy
(N/A)
 
 
  Details
6/8/2020 Myovant Sciences Ltd. MYOV Maintain Buy
(N/A)
 
 
  Details
6/8/2020 Immunomedics IMMU Maintain Neutral
(N/A)
 
 
  Details
6/8/2020 Kiniksa KNSA Maintain Buy
(N/A)
 
 
  Details
6/8/2020 Biohaven Pharmaceutical Holding BHVN Maintain Buy
(N/A)
 
 
  Details
6/8/2020 Amarin Corporation AMRN Maintain Neutral
(N/A)
 
 
  Details
6/8/2020 Magenta Therapeutics MGTA Upgrade Buy
(Neutral)
9.99
(11.58)
15.92% Details
6/5/2020 Viela Bio VIE Maintain Sell
(N/A)
 
 
  Details
6/5/2020 Turning Point Therapeutics Inc. TPTX Maintain Buy
(N/A)
 
 
  Details
6/5/2020 Myovant Sciences Ltd. MYOV Maintain Buy
(N/A)
 
 
  Details
6/5/2020 Kiniksa KNSA Maintain Buy
(N/A)
 
 
  Details
6/5/2020 Biohaven Pharmaceutical Holding BHVN Maintain Buy
(N/A)
 
 
  Details
6/5/2020 Amarin Corporation AMRN Maintain Neutral
(N/A)
 
 
  Details
6/4/2020 Viela Bio VIE Maintain Sell
(N/A)
 
 
  Details
6/2/2020 Viela Bio VIE Maintain Sell
(N/A)
 
 
  Details
6/2/2020 Axcella Health Inc. AXLA Maintain Buy
(N/A)
 
 
  Details
5/8/2020 Puma Biotechnology PBYI Maintain Sell
(N/A)
 
 
  Details
5/6/2020 Clovis Oncology CLVS Maintain Sell
(N/A)
 
 
  Details
4/27/2020 Radius Health RDUS Maintain Buy
(N/A)
 
 
  Details
4/27/2020 Hutchison China MediTech Ltd. HCM Maintain Buy
(N/A)
 
 
  Details
4/27/2020 Global Blood Therapeutics GBT Maintain Neutral
(N/A)
 
 
  Details
4/27/2020 Exelixis EXEL Maintain Neutral
(N/A)
 
 
  Details
4/24/2020 Immunomedics IMMu Upgrade Neutral
(Sell)
21.97
(87.86)
299.91% Details
4/22/2020 Applied Therapeutics APLT New Coverage Buy
(N/A)
35.27
(23.00)
-34.79% Details
4/6/2020 Acceleron Pharma XLRN Downgrade Sell
(Neutral)
83.60
(133.44)
59.62% Details
4/6/2020 Viela Bio VIE Downgrade Sell
(Neutral)
31.99
(53.01)
65.71% Details
3/31/2020 Myovant Sciences Ltd. MYOV Maintain Buy
(N/A)
 
 
  Details
3/31/2020 Amarin Corporation AMRN Downgrade Neutral
(Buy)
13.58
(4.95)
-63.55% Details
3/30/2020 Magenta Therapeutics MGTA Maintain Neutral
(N/A)
 
 
  Details
3/30/2020 Myovant Sciences Ltd. MYOV Maintain Buy
(N/A)
 
 
  Details
3/30/2020 FibroGen FGEN Maintain Neutral
(N/A)
 
 
  Details
3/30/2020 Biohaven Pharmaceutical Holding BHVN Maintain Buy
(N/A)
 
 
  Details
3/30/2020 Immunomedics IMMU Maintain Buy
(N/A)
 
 
  Details
3/30/2020 Nektar Therapeutics NKTR Upgrade Neutral
(Sell)
17.51
(17.61)
0.57% Details
3/26/2020 Frequency Therapeutics FREQ Maintain Buy
(N/A)
 
 
  Details
3/24/2020 BridgeBio Pharma BBIO Maintain Buy
(N/A)
 
 
  Details
3/13/2020 Vir Biotechnology VIR Downgrade Neutral
(Buy)
33.77
(45.53)
34.82% Details
3/13/2020 Amarin Corporation AMRN Upgrade Buy
(Neutral)
12.56
(13.58)
8.12% Details
3/12/2020 Aimmune Therapeutics AIMT Maintain Neutral
(N/A)
 
 
  Details
3/10/2020 Acceleron Pharma XLRN Maintain Neutral
(N/A)
 
 
  Details
3/3/2020 UroGen Pharma URGN Maintain Neutral
(N/A)
 
 
  Details
3/2/2020 UroGen Pharma URGN Maintain Neutral
(N/A)
 
 
  Details
3/2/2020 Nektar Therapeutics NKTR Maintain Sell
(N/A)
 
 
  Details
2/28/2020 Biohaven Pharmaceutical Holding BHVN Maintain Neutral
(N/A)
 
 
  Details
2/25/2020 Esperion Therapeutics ESPR Maintain Neutral
(N/A)
 
 
  Details
2/24/2020 Esperion Therapeutics ESPR Maintain Neutral
(N/A)
 
 
  Details
2/21/2020 Puma Biotechnology PBYI Maintain Sell
(N/A)
 
 
  Details
2/20/2020 Odonate Therapeutics ODT Maintain Sell
(N/A)
 
 
  Details
2/20/2020 Hutchison China MediTech Ltd. HCM New Coverage Buy
(N/A)
27.42
(30.55)
11.42% Details
2/11/2020 Biohaven Pharmaceutical Holding BHVN Maintain Buy
(N/A)
 
 
  Details
2/10/2020 Biohaven Pharmaceutical Holding BHVN Maintain Buy
(N/A)
 
 
  Details
2/4/2020 Axcella Health Inc. AXLA Maintain Buy
(N/A)
 
 
  Details
2/4/2020 Allakos Inc. ALLK New Coverage Neutral
(N/A)
74.04
(93.91)
26.84% Details
2/4/2020 Viela Bio VIE Downgrade Neutral
(Buy)
39.35
(53.01)
34.71% Details
1/29/2020 Acceleron Pharma XLRN Maintain Neutral
(N/A)
 
 
  Details
1/28/2020 Acceleron Pharma XLRN Maintain Neutral
(N/A)
 
 
  Details
12/17/2019 Amarin Corporation AMRN Maintain Neutral
(N/A)
 
 
  Details
12/6/2019 Magenta Therapeutics MGTA New Coverage Neutral
(N/A)
13.12
(11.58)
-11.74% Details
12/6/2019 Odonate Therapeutics ODT New Coverage Sell
(N/A)
34.98
(3.78)
-89.19% Details
12/6/2019 Kiniksa KNSA New Coverage Buy
(N/A)
10.05
(14.86)
47.86% Details
11/25/2019 Global Blood Therapeutics GBT Maintain Neutral
(N/A)
 
 
  Details
11/19/2019 Phathom Pharmaceuticals PHAT New Coverage Neutral
(N/A)
25.87
(34.71)
34.17% Details
11/14/2019 UroGen Pharma URGN Maintain Neutral
(N/A)
 
 
  Details
11/14/2019 NGM Biopharmaceuticals NGM Maintain Buy
(N/A)
 
 
  Details
11/14/2019 Axcella Health Inc. AXLA Maintain Buy
(N/A)
 
 
  Details
11/5/2019 Vir Biotechnology VIR New Coverage Buy
(N/A)
15.00
(45.53)
203.53% Details
11/4/2019 Exelixis EXEL Maintain Neutral
(N/A)
 
 
  Details
10/29/2019 Amarin Corporation AMRN Maintain Neutral
(N/A)
 
 
  Details
10/28/2019 Viela Bio VIE New Coverage Buy
(N/A)
19.65
(53.01)
169.77% Details
10/28/2019 Frequency Therapeutics FREQ New Coverage Buy
(N/A)
14.05
(9.64)
-31.39% Details
10/25/2019 Myovant Sciences Ltd. MYOV Maintain Buy
(N/A)
 
 
  Details
10/25/2019 Aimmune Therapeutics AIMT Maintain Neutral
(N/A)
 
 
  Details
10/24/2019 Myovant Sciences Ltd. MYOV Maintain Buy
(N/A)
 
 
  Details
10/24/2019 Aimmune Therapeutics AIMT Maintain Neutral
(N/A)
 
 
  Details
10/15/2019 Amarin Corporation AMRN New Coverage Neutral
(N/A)
15.22
(4.95)
-67.48% Details
10/8/2019 Spring Works Therapeutics SWTX New Coverage Buy
(N/A)
18.15
(68.20)
275.76% Details
10/8/2019 Nektar Therapeutics NKTR Downgrade Sell
(Buy)
18.97
(17.61)
-7.17% Details
10/8/2019 Clovis Oncology CLVS Maintain Sell
(N/A)
 
 
  Details
10/8/2019 Puma Biotechnology PBYI Downgrade Sell
(Neutral)
10.01
(11.35)
13.39% Details
9/16/2019 Esperion Therapeutics ESPR Upgrade Neutral
(Sell)
36.56
(26.37)
-27.87% Details
8/28/2019 Myovant Sciences Ltd. MYOV New Coverage Buy
(N/A)
7.86
(24.07)
206.23% Details
8/13/2019 UroGen Pharma URGN Maintain Neutral
(N/A)
 
 
  Details
7/22/2019 BridgeBio Pharma BBIO New Coverage Buy
(N/A)
26.00
(63.93)
145.88% Details
6/3/2019 Axcella Health Inc. AXLA New Coverage Buy
(N/A)
14.20
(4.95)
-65.14% Details
5/29/2019 Puma Biotechnology PBYI Maintain Neutral
(N/A)
 
 
  Details
5/29/2019 Acceleron Pharma XLRN New Coverage Neutral
(N/A)
42.06
(133.44)
217.26% Details
5/29/2019 Global Blood Therapeutics GBT New Coverage Neutral
(N/A)
59.93
(40.64)
-32.19% Details
5/29/2019 FibroGen FGEN New Coverage Neutral
(N/A)
35.57
(26.06)
-26.74% Details
5/29/2019 Esperion Therapeutics ESPR New Coverage Sell
(Neutral)
52.33
(36.56)
-30.14% Details
5/29/2019 Clovis Oncology CLVS New Coverage Sell
(Neutral)
16.74
(5.78)
-65.47% Details
5/29/2019 Radius Health RDUS New Coverage Buy
(Neutral)
21.11
(18.81)
-10.9% Details
5/29/2019 UroGen Pharma URGN New Coverage Neutral
(N/A)
36.52
(17.31)
-52.6% Details
5/13/2019 Turning Point Therapeutics Inc. TPTX New Coverage Buy
(N/A)
33.48
(74.93)
123.81% Details
5/6/2019 Biohaven Pharmaceutical Holding BHVN New Coverage Buy
(N/A)
57.14
(105.02)
83.79% Details
4/29/2019 NGM Biopharmaceuticals NGM New Coverage Buy
(N/A)
15.57
(18.30)
17.53% Details
4/26/2019 The Medicines Company MDCO Upgrade Buy
(Neutral)
29.46
(84.90)
188.19% Details
4/26/2019 Esperion Therapeutics ESPR Upgrade Neutral
(Sell)
41.91
(52.33)
24.86% Details
12/20/2018 Aimmune Therapeutics AIMT Maintain Neutral
(N/A)
 
 
  Details
12/13/2018 Array BioPharma ARRY New Coverage Neutral
(N/A)
15.45
(16.15)
4.53% Details
12/13/2018 Aimmune Therapeutics AIMT New Coverage Neutral
(N/A)
23.23
(34.49)
48.47% Details
12/13/2018 The Medicines Company MDCO New Coverage Neutral
(N/A)
20.70
(29.46)
42.32% Details
12/13/2018 Esperion Therapeutics ESPR New Coverage Sell
(N/A)
52.90
(41.91)
-20.78% Details
12/13/2018 Nektar Therapeutics NKTR New Coverage Buy
(N/A)
36.43
(17.61)
-51.66% Details
12/13/2018 Neurocrine Bio. NBIX New Coverage Buy
(N/A)
85.76
(130.36)
52.01% Details
11/19/2018 Puma Biotechnology PBYI Upgrade Neutral
(Sell)
22.61
(11.35)
-49.8% Details
9/17/2018 Puma Biotechnology PBYI New Coverage Sell
(N/A)
48.35
(22.61)
-53.24% Details
9/17/2018 Loxo Oncology LOXO New Coverage Neutral
(N/A)
165.38
(234.80)
41.98% Details
9/17/2018 Exelixis EXEL New Coverage Neutral
(N/A)
16.71
(22.98)
37.52% Details
9/17/2018 Immunomedics IMMU New Coverage Buy
(N/A)
22.61
(21.97)
-2.83% Details